Compare PETS & UG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PETS | UG |
|---|---|---|
| Founded | 1996 | 1942 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail-Drug Stores and Proprietary Stores | Package Goods/Cosmetics |
| Sector | Consumer Staples | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.0M | 30.8M |
| IPO Year | 2003 | 1995 |
| Metric | PETS | UG |
|---|---|---|
| Price | $1.85 | $7.01 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 195.7K | 4.4K |
| Earning Date | 06-09-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 7.10% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.20 |
| Revenue | ★ $273,800,000.00 | $10,545,468.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.98 | N/A |
| P/E Ratio | ★ N/A | $35.10 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.57 | $5.58 |
| 52 Week High | $4.10 | $9.88 |
| Indicator | PETS | UG |
|---|---|---|
| Relative Strength Index (RSI) | 38.13 | 51.94 |
| Support Level | $1.62 | $6.79 |
| Resistance Level | $2.41 | $7.43 |
| Average True Range (ATR) | 0.13 | 0.18 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 33.56 | 23.81 |
PetMed Express Inc is a nationwide direct-to-consumer pet pharmacy and online provider of prescription and non-prescription medications, foods, supplements, supplies, and vet services for dogs, cats, and horses. It markets and sells directly to consumers through its websites, toll-free numbers, and mobile application, offering convenience, price, speed of delivery, and customer service. It provides access to branded pharmaceuticals, generic medications, compounded prescription medications, over-the-counter health and wellness products, prescription and non-prescription food, pharmacy fulfillment, and AutoShip capabilities. Its digital platform offers pet healthcare solutions for chronic conditions, including allergies, arthritis, anxiety, kidney-related conditions, and hyperthyroidism.
United-Guardian Inc manufactures, markets and develops specialty cosmetic, personal care and sexual wellness ingredients, and a line of healthcare products including pharmaceuticals and medical lubricants. Its pharmaceutical products are distributed through national drug wholesalers to pharmacies, physicians, and hospitals. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. The company's majority of revenue is derived from the sales of Pharmaceuticals in the United States.